Société Summit Therapeutics plc London S.E.
Actions
GB00BN40HZ01
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11/11/20 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/12/19 |
Director of Finance/CFO | 46 | 01/12/19 | |
Howard West
CTO | Chief Tech/Sci/R&D Officer | - | 19/10/23 |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 16/10/23 |
Will Black
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dave Gancarz
PRN | Corporate Officer/Principal | - | - |
Campbell Hair
HRO | Human Resources Officer | - | 01/10/20 |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03/11/21 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 01/06/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/12/19 |
Robert Booth
BRD | Director/Board Member | 70 | 28/09/22 |
Director of Finance/CFO | 46 | 01/12/19 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11/11/20 |
Kenneth Clark
BRD | Director/Board Member | 65 | 07/10/21 |
Director/Board Member | 63 | 15/11/22 | |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 03/11/21 |
Michelle Xia
BRD | Director/Board Member | 58 | 16/01/23 |
Ujwala Mahatme
BRD | Director/Board Member | 59 | 13/07/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 701 979 596 | 83 228 173 ( 11,86 %) | 0 | 11,86 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+12,30% | 116 Md | |
+12,15% | 106 Md | |
-8,14% | 23,89 Md | |
-1,69% | 21,58 Md | |
-10,60% | 18,96 Md | |
-41,25% | 16,96 Md | |
-15,33% | 16,33 Md | |
+5,80% | 14,14 Md | |
+28,03% | 12,02 Md |